Protein thought to promote cancer instead functions as a tumor suppressor, researchers report

July 08, 2008

A protein previously thought to promote colorectal cancer instead suppresses the growth of human cancer cells in culture, researchers at UT Southwestern Medical Center have found.

"This finding reshapes a fundamental model of how colorectal cancer arises," said Dr. Lawrence Lum, assistant professor of cell biology at UT Southwestern and senior author of the study, which appears online today and in a future issue of the Proceedings of the National Academy of Sciences.

Approximately 90 percent of colorectal cancers are caused by a biochemical malfunction that arises from mutations in a gene that activates a gene called TCF7L2, Dr. Lum said. As a result, TCF7L2 has been suspected of helping to trigger colorectal cancer.

In the current study, the researchers used a novel genetic screening approach known as RNAi mediated interference, or RNAi, to identify genes that contributed to this malfunction.

The researchers employed more than 80,000 small snippets of chemically synthesized RNAs (ribonucleic acids) known as "small interfering RNAs" or siRNAs, that are each capable of inactivating a specific gene. The researchers mixed these siRNAs with specially engineered human cancer cells that glowed when the cancer-causing malfunction is activated. When an siRNA made a cell glow, the researchers were able to flag the gene as a candidate cancer gene.

As the researchers examined the genes of interest more closely, they unexpectedly found that a gene called TCF7L2, which had been thought to boost malignant cell growth, instead suppressed it. When the gene was inactivated, human colorectal cancer cells grew more rapidly in culture and emitted a stronger glow.

"The function of TCF7L2 in cancer was previously determined from studies in animals but no one has genetically tested its role in human colorectal cancer cells before," said Dr. Lum, who is a Virginia Murchison Linthicum Scholar in Medical Research. "Prior to the advent of RNAi technology, this was very difficult to do in human cultured cells."

The next step is to understand more fully all the steps in the biochemical pathway involved in controlling the action of TCF7L2. This knowledge could then be used to identify new therapeutic targets for treating colorectal cancer. Therapeutic strategies derived from such studies may also be useful in treating type II diabetes, for which risk is strongly associated with mutations in TCF7L2, Dr. Lum said.

Dr. Lum noted that the findings about TCF7L2 show the effectiveness of this high throughput screening technique, which can quickly and systematically check many thousands of genes.

The success of this relatively new screening method for identifying candidate cancer genes demonstrates its usefulness to understanding human disease, Dr. Lum said.

"It's a way to analyze human gene action directly in human tissue at a genome-scale," he said.

Other UT Southwestern researchers involved in the study were Dr. Wei Tang, postdoctoral researcher in cell biology; graduate student Michael Dodge; former laboratory technician Deepika Gundapaneni; Dr. Carolyn Michnoff, former manager of the High-Throughput Screening facility; and Dr. Michael Roth, professor of biochemistry.

The work was supported by the National Institutes of Health, the American Cancer Society, and the Welch Foundation.

Visit http://www.utsouthwestern.org/urology to learn more about UT Southwestern's clinical services in urology. Visit http://www.utsouthwestern.org/cancercenter for additional information about UT Southwestern's clinical services in cancer.


The University of Texas Southwestern Medical Center at Dallas

---

---

	American Cancer Society's Complete Guide to Colorectal Cancer by American Cancer Society (Author), Bernard Levin (Editor), Terri Ades (Editor), Katie Couric (Editor) Created by a prestigious panel of experts, this new book offers comprehensive coverage of colorectal cancer, the second most prevalent form of cancer in the world, which, with proper screening, is almost entirely preventable. It provides up-to-date, essential information about the disease, including prevention, detection, diagnosis, treatment options, complementary and alternative therapies, coping, living well with cancer, caregiving, and much more. Throughout the text real cancer survivors offer their experience dealing with this disease, from diagnosis to treatment and beyond.
	ABC of Colorectal Cancer (ABC Series) by Annie Young (Editor), Richard Hobbs (Editor), David Kerr (Editor) Colorectal cancer is a common cause of morbidity and mortality in which prevention, screening and early detection are vital. Beginning with the patient perspective and following the patient pathway, this new second edition covers epidemiology and prevention, screening programmes, decision support networks, the role of primary care, and supportive care for patients with colorectal cancer.The ABC of Colorectal Cancer provides the core knowledge on clinical genetics, diagnosis, imaging, therapy and surgery options and the latest evidence based guidelines for treating and managing colorectal cancer patients within the multidisciplinary team. Highly illustrated and accessible, it covers the full spectrum of the disease to provide the basis to make a real difference to clinical management.This...
	Be a Survivor Colorectal Cancer Treatment Guide by Vladimir Lange (Author) Dr. Lange’s comprehensive overview of cancer and treatment options offers detailed information using simple, concise language and a wide variety of color photos and drawings. Colorectal cancer patients need to know more about their disease, yet there is an overload of information. Be a Survivor gives the patient the specific, reliable and necessary information to make good decisions about their cancer and treatment options. Annually, 150,000 Americans are told they have colorectal cancer, making it one of the top three most common cancers in the United States. Diagnosed early, colorectal cancer is treatable, often curable, and vey preventable. This resource covers all aspects of colorectal cancer—from diagnosis to recovery, including a chapter for the patient's spouse.
	What Your Doctor May Not Tell You About(TM) Colorectal Cancer: New Tests, New Treatments, New Hope by Mark Bennett Pochapin (Author) - What Your Doctor May Not Tell You About Colorectal Cancer was published in Warner hardcover (0-446-53188-X) in 3/04. The book features a foreword by Katie Couric. - Dr. Pochapin made an appearance on the Today show in conjunction with the hardcover publication of this book. Previously, he had been chosen by Katie Couric to be the Medical Director of the Jay Monahan Center for Gastrointestinal Health, named in honor of Ms. Couric's late husband. - The author is an associate professor of clinical medicine at the Weill Medical College of Cornell University and Chief of Gastrointestinal Endoscopy at New York Presbyterian Hospital's Weill Cornell Medical Center. - There are approximately 100,000 new colorectal cancer cases diagnosed annually, making it the second leading cause of...
	Positive Options for Colorectal Cancer: Self-Help and Treatment by Carol Ann Larson (Author), Kathleen Ogle (Foreword) Colorectal cancer develops slowly over a period of several years, undetected, usually as polyps. It is a preventable and treatable disease if caught in time, yet most know little about how to read its symptoms. Written for the layperson, this book covers all the uncomfortable questions and answers about the disease, from prevention and warning signs, to screening and diagnosis techniques, to making decisions and developing treatment plans. Also included are positive stories about life after cancer by 12 survivors.
	COPING WITH COLORECTAL CANCER by Crystal Night Books DESCRIPTION: Coping With Colorectal Cancer – the prevention and cure of the second leading cause of cancer deaths is dedicated to helping reduce the toll this disease takes on human lives. It aims at prevention by teaching people to avoid the risk factors that lead to the disease, to save lives through leading victims to early detection, and presenting treatment options to those patients diagnosed with the disease. Colorectal cancer, also commonly called bowel cancer, is caused by uncontrolled cell growth in the colon, rectum, or appendix. Actually the majority colorectal cancers occurs due to lifestyle and increasing age, while a minority of cases are associated with underlying genetic disorders. Colorectal cancer typically starts in the lining of the bowel and...
	Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology) by Leonard B. Saltz (Editor) Recent advances in the understanding of the biology of colorectal cancer have radically transformed the treatment options available to clinicians, leaving textbooks written only two years ago completely out of date. This evidence-based and data-driven guide presents reviews of cutting-edge therapies for colorectal cancer, all articulated by leading experts in the field. This integrated and focused consideration of colorectal management includes reviews of cytotoxic chemotherapy, targeted biologic therapies, as well as updates on adjuvant chemotherapy for colon cancer and combined modality management of rectal cancers. Attention is also focussed on the role of potentially curative multi-modality management of liver metastases, with considerations of the role of liver resection and...
	Colorectal Cancer Screening (Clinical Gastroenterology) by Joseph Anderson MD (Editor), Charles Kahi MD (Editor) Colorectal Cancer Screening provides a complete overview of colorectal cancer screening, from epidemiology and molecular abnormalities, to the latest screening techniques such as stool DNA and FIT, Computerized Tomography (CT) Colonography, High Definition Colonoscopes and Narrow Band Imaging. As the text is devoted entirely to CRC screening, it features many facts, principles, guidelines and figures related to screening in an easy access format. This volume provides a complete guide to colorectal cancer screening which will be informative to the subspecialist as well as the primary care practitioner. It represents the only text that provides this up to date information about a subject that is continually changing. For the primary practitioner, information on the guidelines for screening...
	100 Questions & Answers About Colorectal Cancer by David Bub (Author), Susannah L. Rose (Author), W. Douglas Wong (Author) Whether You’Re A Newly Diagnosed Cancer Patient, A Survivor, Or A Friend Or Relative Of Either, This Book Offers Help. The Only Text To Provide The Doctor’S And Patient’S View, The Second Edition Is Updated With Authoritative, Practical Answers To Your Questions About Treatment Options, Post-Treatment Quality Of Life, Sources Of Support, And Much More. This Book Is An Invaluable Resource For Anyone Coping With The Physical And Emotional Turmoil Of This Frightening Disease. The Authors Consist Of Two Oncologic Surgeons And A Cancer Care Social Worker From Memorial Sloan-Kettering Cancer Center. Commentary From Actual Colon And Rectal Cancer Survivors Provides A Unique, “Insider’S” Perspective.
	Towdah: A Cancer Survivor's Song of Hope by Sheryl Holmes (Author) Towdah is one Hebrew word for thanksgiving used in the Scriptures. This song is the author's offering of thanks given despite the suffering and difficult circumstances that she endured while dealing with cancer. Sheryl Holmes says, "I lift up my hands in praise to my Abba Father and I thank Him for what He has done and for what He has not even yet done, but will do, because I trust Him. It is my desire that Towdah: A Cancer Survivor’s Song of Hope will display the sparkle of God in my life and the praise that I cannot keep to myself. Read my story and be encouraged, my friend."